Alzheimer Hastalığı
References
Gustafson L. What is dementia? Acta Neurologica Scandinavic; 1996; 94(168), 22-24. doi:10.1111/j.1600-0404.1996.tb00367.x
Keleş E, Özalevli S. Alzheimer Hastalığı ve Tedavi Yaklaşımları. İzmir Kâtip Çelebi Üniversitesi Sağlık Bilimleri Fakültesi Dergisi; 2018; 3(2), 39-42.
Aarsland D. Epidemiology and Pathophysiology of Dementia-Related Psychosis. J Clin Psychiatry; 2020; 15;81(5). doi:10.4088/JCP.AD19038BR1C
Zvěřová M. Clinical aspects of Alzheimer's disease. Clin Biochem; 2019; 72:3-6. doi:10.1016/j.clinbiochem.2019.04.015
Twarowski B, Herbet M. Inflammatory Processes in Alzheimer's Disease-Pathomechanism, Diagnosis and Treatment: A Review. International journal of molecular sciences; 2023; 24(7):6518. doi:10.3390/ijms24076518
2023 Alzheimer's disease facts and figures. Alzheimers Dement; 2023; 19(4):1598-1695. doi:10.1002/alz.13016
Ma C, Hong F, Yang S. Amyloidosis in Alzheimer's Disease: Pathogeny, Etiology, and Related Therapeutic Directions. Molecules; 2022; 27(4):1210. doi:10.3390/molecules27041210
Breijyeh Z, Karaman R. Comprehensive Review on Alzheimer's Disease: Causes and Treatment. Molecules; 2020; 25(24):5789. doi:10.3390/molecules25245789
Yu H, Wu J. Amyloid-β: A double agent in Alzheimer's disease?. Biomed Pharmacother; 2021; 139, 111575. doi:10.1016/j.biopha.2021.111575
Sheppard O, Coleman M. Alzheimer’s Disease: Etiology, Neuropathology and Pathogenesis. In: Huang X, (ed). Alzheimer’s Disease: Drug Discovery. Brisbane (AU): Exon Publications; 2020; Chapter 1. Doi: 10.36255/exonpublications.alzheimersdisease.2020.ch1
De la Rosa A, Olaso-Gonzalez G, Arc-Chagnaud C, Millan F, Salvador-Pascual A, García-Lucerga C, Blasco-Lafarga C, Garcia-Dominguez E, Carretero A, Correas AG, Viña J, Gomez-Cabrera MC. Physical exercise in the prevention and treatment of Alzheimer's disease. Journal of sport and health science; 2020; 9(5), 394–404. doi:10.1016/j.jshs.2020.01.004
Selekler K. Alois Alzheimer ve Alzheimer Hastalığı. Türkiye Geriatri Dergisi; 2010; 13(3), 9-14.
Passeri E, Elkhoury K, Morsink M, Broersen K, Linder M, Tamayol A, Malaplate C, Yen F, Arab-Tehrany E. Alzheimer's Disease: Treatment Strategies and TheirLimitations. International journal of molecular sciences; 2022; 23(22), 13954. doi:10.3390/ijms232213954
DeTure MA, Dickson DW. The neuropathological diagnosis of Alzheimer's disease. Molecular neurodegeneration; 2019; 14(1), 32. doi:10.1186/s13024-019-0333-5
Liu RM. Aging, Cellular Senescence, and Alzheimer's Disease. International journal of molecular sciences; 2022; 23(4), 1989. doi:10.3390/ijms23041989
Öztürk G, Karan M. Alzheimer Hastalığının Fizyopatolojisi. Klinik Gelişim; 2009; 22(3), 36-45.
Açık M, Yabancı Ayhan N. D Vitamini ve Alzheimer Hastalığı. Adıyaman Üniversitesi Sağlık Bilimleri Dergisi; 2018; 4(2), 980-991. https://doi.org/10.30569/adiyamansaglik.415027
Walker L. Aβ Plaques. Free Neuropathology; 2020; 1(31). doi:10.17879/freeneuropathology-2020-3025
Moh C, Kubiak JZ, Bajic VP, Zhu X, Smit, MA, Lee, HG. Cell cycle deregulation in the neurons of Alzheimer's disease. Results and problems in cell differentiation; 2011; 53, 565–576. doi:10.1007/978-3-642-19065-0_23
Naseri NN, Wang H, Guo J, Sharma M, Luo W. The complexity of tau in Alzheimer's disease. Neuroscience letters; 2019; 705, 183–194. doi:10.1016/j.neulet.2019.04.022
Braak H, Braak E. Neuropathological stageing of Alzheimer-related changes. Acta neuropathologica; 1991; 82(4), 239–259. doi:10.1007/BF00308809
Hua X, Lei M, Zhang Y, Ding J, Han Q, Hu G, Xiao M.. Long-term D-galactose injection combined with ovariectomy serves as a new rodent model for Alzheimer's disease. Life sciences; 2007; 80(20), 1897–1905. doi:10.1016/j.lfs.2007.02.030
Das M, Jaya Balan D, Kasi PD. Mitigation of oxidative stress with dihydroactinidiolide, a natural product against scopolamine-induced amnesia in Swiss albino mice, NeuroToxicology; 2021; 86, 149-161. doi:10.1016/j.neuro.2021.08.003
Tang K. The cellular and molecular processes associated with scopolamine-induced memory deficit: A model of Alzheimer's biomarkers. Life Sciences; 2019; 233, 116695. doi:10.1016/j.lfs.2019.116695
Kamat P, Kalani A, Rai S, et al. Streptozotocin Intracerebroventricular-Induced Neurotoxicity and Brain Insulin Resistance: a Therapeutic Intervention for Treatment of Sporadic Alzheimer’s Disease (sAD)-Like Pathology. Molecular Neurobiology; 2016; 53, 4548–4562. doi:10.1007/s12035-015-9384-y
Chen X, Zhang M, Ahmed M, Surapaneni KM, Veeraraghavan VP, Arulselvan P. Neuroprotective effects of ononin against the aluminium chloride-induced Alzheimer's disease in rats. Saudi journal of biological sciences; 2021; 28(8), 4232–4239. doi:10.1016/j.sjbs.2021.06.031
Elmorsy E, Elsharkawy E, Alhumaydhi FA, Salama M. The protective effect of Indian Catechu methanolic extract against aluminum chloride-induced neurotoxicity, A rodent model of Alzheimer's disease. Heliyon; 2021; 7(2), e06269. doi:10.1016/j.heliyon.2021.e06269
He C, Zhao X, Lei Y, Nie J, Lu X, Song J, Wang L, Li H, Liu F, Zhang Y, Niu Q. Whole-transcriptome analysis of aluminum-exposed rat hippocampus and identification of ceRNA networks to investigate neurotoxicity of Al. Molecular therapy. Nucleic acids; 2021; 26, 1401–1417. doi:10.1016/j.omtn.2021.11.010
Kadar T, Dachir S, Shukitt-Hale B, Levy A. Sub-regional hippocampal vulnerability in various animal models leading to cognitive dysfunction. J Neural Transm; 1998; 105 (8-9), 987–1004. doi:10.1007/s007020050107
Turunc Bayrakdar E, Uyanikgil Y, Kanit L, Koylu E, Yalcin A. Nicotinamide treatment reduces the levels of oxidative stress, apoptosis, and PARP-1 activity in Aβ(1–42)-induced rat model of Alzheimer's disease. Free Radical Research; 2014; 48(2), 146–158. doi:10.3109/10715762.2013.857018
Benzigül S, Çam SA, Uysal F, Arslan SO, Tatlı Doğan H. Arı Sütünün Amiloid Beta ile Deneysel Alzheimer Modeli Oluşturulmuş Sıçanlarda Etkileri. Dicle Tıp Dergisi; 2021; 48(3), 595-604. https://doi.org/10.5798/dicletip.988081
Keleş E, Özalevli S. Alzheimer Hastalığı ve Tedavi Yaklaşımları. İzmir Kâtip Çelebi Üniversitesi Sağlık Bilimleri Fakültesi Dergisi; 2018; 3(2), 39-42.
Aarsland D. Epidemiology and Pathophysiology of Dementia-Related Psychosis. J Clin Psychiatry; 2020; 15;81(5). doi:10.4088/JCP.AD19038BR1C
Zvěřová M. Clinical aspects of Alzheimer's disease. Clin Biochem; 2019; 72:3-6. doi:10.1016/j.clinbiochem.2019.04.015
Twarowski B, Herbet M. Inflammatory Processes in Alzheimer's Disease-Pathomechanism, Diagnosis and Treatment: A Review. International journal of molecular sciences; 2023; 24(7):6518. doi:10.3390/ijms24076518
2023 Alzheimer's disease facts and figures. Alzheimers Dement; 2023; 19(4):1598-1695. doi:10.1002/alz.13016
Ma C, Hong F, Yang S. Amyloidosis in Alzheimer's Disease: Pathogeny, Etiology, and Related Therapeutic Directions. Molecules; 2022; 27(4):1210. doi:10.3390/molecules27041210
Breijyeh Z, Karaman R. Comprehensive Review on Alzheimer's Disease: Causes and Treatment. Molecules; 2020; 25(24):5789. doi:10.3390/molecules25245789
Yu H, Wu J. Amyloid-β: A double agent in Alzheimer's disease?. Biomed Pharmacother; 2021; 139, 111575. doi:10.1016/j.biopha.2021.111575
Sheppard O, Coleman M. Alzheimer’s Disease: Etiology, Neuropathology and Pathogenesis. In: Huang X, (ed). Alzheimer’s Disease: Drug Discovery. Brisbane (AU): Exon Publications; 2020; Chapter 1. Doi: 10.36255/exonpublications.alzheimersdisease.2020.ch1
De la Rosa A, Olaso-Gonzalez G, Arc-Chagnaud C, Millan F, Salvador-Pascual A, García-Lucerga C, Blasco-Lafarga C, Garcia-Dominguez E, Carretero A, Correas AG, Viña J, Gomez-Cabrera MC. Physical exercise in the prevention and treatment of Alzheimer's disease. Journal of sport and health science; 2020; 9(5), 394–404. doi:10.1016/j.jshs.2020.01.004
Selekler K. Alois Alzheimer ve Alzheimer Hastalığı. Türkiye Geriatri Dergisi; 2010; 13(3), 9-14.
Passeri E, Elkhoury K, Morsink M, Broersen K, Linder M, Tamayol A, Malaplate C, Yen F, Arab-Tehrany E. Alzheimer's Disease: Treatment Strategies and TheirLimitations. International journal of molecular sciences; 2022; 23(22), 13954. doi:10.3390/ijms232213954
DeTure MA, Dickson DW. The neuropathological diagnosis of Alzheimer's disease. Molecular neurodegeneration; 2019; 14(1), 32. doi:10.1186/s13024-019-0333-5
Liu RM. Aging, Cellular Senescence, and Alzheimer's Disease. International journal of molecular sciences; 2022; 23(4), 1989. doi:10.3390/ijms23041989
Öztürk G, Karan M. Alzheimer Hastalığının Fizyopatolojisi. Klinik Gelişim; 2009; 22(3), 36-45.
Açık M, Yabancı Ayhan N. D Vitamini ve Alzheimer Hastalığı. Adıyaman Üniversitesi Sağlık Bilimleri Dergisi; 2018; 4(2), 980-991. https://doi.org/10.30569/adiyamansaglik.415027
Walker L. Aβ Plaques. Free Neuropathology; 2020; 1(31). doi:10.17879/freeneuropathology-2020-3025
Moh C, Kubiak JZ, Bajic VP, Zhu X, Smit, MA, Lee, HG. Cell cycle deregulation in the neurons of Alzheimer's disease. Results and problems in cell differentiation; 2011; 53, 565–576. doi:10.1007/978-3-642-19065-0_23
Naseri NN, Wang H, Guo J, Sharma M, Luo W. The complexity of tau in Alzheimer's disease. Neuroscience letters; 2019; 705, 183–194. doi:10.1016/j.neulet.2019.04.022
Braak H, Braak E. Neuropathological stageing of Alzheimer-related changes. Acta neuropathologica; 1991; 82(4), 239–259. doi:10.1007/BF00308809
Hua X, Lei M, Zhang Y, Ding J, Han Q, Hu G, Xiao M.. Long-term D-galactose injection combined with ovariectomy serves as a new rodent model for Alzheimer's disease. Life sciences; 2007; 80(20), 1897–1905. doi:10.1016/j.lfs.2007.02.030
Das M, Jaya Balan D, Kasi PD. Mitigation of oxidative stress with dihydroactinidiolide, a natural product against scopolamine-induced amnesia in Swiss albino mice, NeuroToxicology; 2021; 86, 149-161. doi:10.1016/j.neuro.2021.08.003
Tang K. The cellular and molecular processes associated with scopolamine-induced memory deficit: A model of Alzheimer's biomarkers. Life Sciences; 2019; 233, 116695. doi:10.1016/j.lfs.2019.116695
Kamat P, Kalani A, Rai S, et al. Streptozotocin Intracerebroventricular-Induced Neurotoxicity and Brain Insulin Resistance: a Therapeutic Intervention for Treatment of Sporadic Alzheimer’s Disease (sAD)-Like Pathology. Molecular Neurobiology; 2016; 53, 4548–4562. doi:10.1007/s12035-015-9384-y
Chen X, Zhang M, Ahmed M, Surapaneni KM, Veeraraghavan VP, Arulselvan P. Neuroprotective effects of ononin against the aluminium chloride-induced Alzheimer's disease in rats. Saudi journal of biological sciences; 2021; 28(8), 4232–4239. doi:10.1016/j.sjbs.2021.06.031
Elmorsy E, Elsharkawy E, Alhumaydhi FA, Salama M. The protective effect of Indian Catechu methanolic extract against aluminum chloride-induced neurotoxicity, A rodent model of Alzheimer's disease. Heliyon; 2021; 7(2), e06269. doi:10.1016/j.heliyon.2021.e06269
He C, Zhao X, Lei Y, Nie J, Lu X, Song J, Wang L, Li H, Liu F, Zhang Y, Niu Q. Whole-transcriptome analysis of aluminum-exposed rat hippocampus and identification of ceRNA networks to investigate neurotoxicity of Al. Molecular therapy. Nucleic acids; 2021; 26, 1401–1417. doi:10.1016/j.omtn.2021.11.010
Kadar T, Dachir S, Shukitt-Hale B, Levy A. Sub-regional hippocampal vulnerability in various animal models leading to cognitive dysfunction. J Neural Transm; 1998; 105 (8-9), 987–1004. doi:10.1007/s007020050107
Turunc Bayrakdar E, Uyanikgil Y, Kanit L, Koylu E, Yalcin A. Nicotinamide treatment reduces the levels of oxidative stress, apoptosis, and PARP-1 activity in Aβ(1–42)-induced rat model of Alzheimer's disease. Free Radical Research; 2014; 48(2), 146–158. doi:10.3109/10715762.2013.857018
Benzigül S, Çam SA, Uysal F, Arslan SO, Tatlı Doğan H. Arı Sütünün Amiloid Beta ile Deneysel Alzheimer Modeli Oluşturulmuş Sıçanlarda Etkileri. Dicle Tıp Dergisi; 2021; 48(3), 595-604. https://doi.org/10.5798/dicletip.988081
Pages
67-76
Published
January 14, 2025
Copyright (c) 2025 Academician Publishing Book Portal
